{"id":"https://openalex.org/W2888474255","doi":null,"title":"[F-18]norchlorofluorepibatidine (NFED): Preclinical toxicological studies","display_name":"[F-18]norchlorofluorepibatidine (NFED): Preclinical toxicological studies","publication_year":1996,"publication_date":"1996-12-31","ids":{"openalex":"https://openalex.org/W2888474255","mag":"2888474255"},"language":"en","primary_location":{"id":"mag:2888474255","doi":null,"is_oa":false,"landing_page_url":"https://www.rti.org/publication/f-18norchlorofluorepibatidine-nfed-preclinical-toxicological-studies","pdf_url":null,"source":null,"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":null},"volume":null,"type":"article","indexed_in":[],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5111506642","display_name":"J G Fowler","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"J G Fowler","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5082242825","display_name":"Naji N. Abumrad","orcid":"https://orcid.org/0000-0002-6874-6306","observed_orcids":["https://orcid.org/0000-0002-6874-6306"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Naji N. Abumrad","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0002-6874-6306","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5109552211","display_name":"Pamela S. King","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Pamela S. King","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5112149186","display_name":"Naomi R. Pappas","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"N. Pappas","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5104070676","display_name":"Michael J. Kuhar","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"M. J. Kuhar","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0002-9877-4076","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5002969658","display_name":"Nora D. Volkow","orcid":"https://orcid.org/0000-0001-6668-0908","observed_orcids":["https://orcid.org/0000-0001-6668-0908"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Nora D. Volkow","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":null,"display_name":"Feng\u2010Xia Liang","orcid":"https://orcid.org/0000-0003-0037-4590","observed_orcids":["https://orcid.org/0000-0003-0037-4590"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Feng\u2010Xia Liang","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0003-0037-4590","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5112366469","display_name":"Frank Ivy Carroll","orcid":"https://orcid.org/0000-0001-9510-765X","observed_orcids":["https://orcid.org/0000-0001-9510-765X"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"F Carroll","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5084754173","display_name":"YS Ding","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"YS Ding","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5111477761","display_name":"Pedro Molina","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Pedro Molina","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.0,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":{"value":0.44577098,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11395","display_name":"Radiopharmaceutical Chemistry and Applications","score":0.1891999989748001,"subfield":{"id":"https://openalex.org/subfields/2741","display_name":"Radiology, Nuclear Medicine and Imaging"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11395","display_name":"Radiopharmaceutical Chemistry and Applications","score":0.1891999989748001,"subfield":{"id":"https://openalex.org/subfields/2741","display_name":"Radiology, Nuclear Medicine and Imaging"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12229","display_name":"Pharmacological Effects and Toxicity Studies","score":0.1331000030040741,"subfield":{"id":"https://openalex.org/subfields/2735","display_name":"Pediatrics, Perinatology and Child Health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T14072","display_name":"Immunotoxicology and immune responses","score":0.10819999873638153,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/fluorine-18-radiotracer","display_name":"fluorine-18 radiotracer","score":0.7799999713897705},{"id":"https://openalex.org/keywords/epibatidine","display_name":"epibatidine","score":0.5640000104904175},{"id":"https://openalex.org/keywords/preclinical-toxicology","display_name":"preclinical toxicology","score":0.734000027179718}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.2804849147796631}],"mesh":[],"locations_count":1,"locations":[{"id":"mag:2888474255","doi":null,"is_oa":false,"landing_page_url":"https://www.rti.org/publication/f-18norchlorofluorepibatidine-nfed-preclinical-toxicological-studies","pdf_url":null,"source":null,"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":null}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.5683000087738037}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2751469606","https://openalex.org/W2406369251","https://openalex.org/W2407384591","https://openalex.org/W2398091836","https://openalex.org/W2417836279","https://openalex.org/W3087120056","https://openalex.org/W2737421953","https://openalex.org/W2582628284","https://openalex.org/W1584872038","https://openalex.org/W2404282006"],"abstract_inverted_index":null,"counts_by_year":[],"updated_date":"2026-11-06T12:05:46.655746","created_date":"2018-08-31T00:00:00"}